These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9424550)

  • 1. [Improved knowledge resulted in better care of ALS].
    Conradi S; Ronnevi LO
    Lakartidningen; 1997 Nov; 94(48):4484-6, 4489-92. PubMed ID: 9424550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology and treatment of amyotrophic lateral sclerosis].
    Camu W
    Soins; 2008 Jun; (726):40-3. PubMed ID: 18697338
    [No Abstract]   [Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis: a team approach to primary care.
    Houde SC; Mangolds V
    Clin Excell Nurse Pract; 1999 Nov; 3(6):337-45. PubMed ID: 10865571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
    Dib M
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG
    IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group.
    Andersen PM; Borasio GD; Dengler R; Hardiman O; Kollewe K; Leigh PN; Pradat PF; Silani V; Tomik B;
    Amyotroph Lateral Scler; 2007 Aug; 8(4):195-213. PubMed ID: 17653917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdisciplinary palliative care, including massage, in treatment of amyotrophic lateral sclerosis.
    Blatzheim K
    J Bodyw Mov Ther; 2009 Oct; 13(4):328-35. PubMed ID: 19761955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database.
    Miller RG; Anderson F; Brooks BR; Mitsumoto H; Bradley WG; Ringel SP;
    Ann Neurol; 2009 Jan; 65 Suppl 1():S24-8. PubMed ID: 19191307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
    Leigh PN; Swash M; Iwasaki Y; Ludolph A; Meininger V; Miller RG; Mitsumoto H; Shaw P; Tashiro K; Van Den Berg L
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):84-98. PubMed ID: 15204010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments against.
    Ludolph AC; Riepe MW
    Neurology; 1999; 53(8 Suppl 5):S46-9; discussion S55-7. PubMed ID: 10560638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic advances: new hope for patients with ALS.
    Forshew DA
    Nurs Spectr (Wash D C); 1998 Dec; 8(25):12-4. PubMed ID: 10542672
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing patients with amyotrophic lateral sclerosis.
    Sathasivam S
    Eur J Intern Med; 2009 Jul; 20(4):355-8. PubMed ID: 19524172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a better understanding of amyotrophic lateral sclerosis.
    Hoffman JJ
    Home Healthc Nurse; 2008 Jun; 26(6):337-42; quiz 343-4. PubMed ID: 18562817
    [No Abstract]   [Full Text] [Related]  

  • 15. What has changed with riluzole?
    Meininger V; Lacomblez L; Salachas F
    J Neurol; 2000 Dec; 247 Suppl 6():VI/19-22. PubMed ID: 19714404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis.
    Jusić A; Ries M; Sostarko M
    Neurol Croat; 1992; 41(4):213-26. PubMed ID: 1281433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What has changed with riluzole?
    Meininger V; Lacomblez L; Salachas F
    J Neurol; 2000 Dec; 247():19-22. PubMed ID: 11200701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Riluzole as a treatment for amyotrophic lateral sclerosis].
    Borrás-Blasco J; Plaza-Macías I; Navarro-Ruiz A; Perís-Martí J; Antón-Cano A
    Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
    Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.